COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,676 Articles (22,913 medRxiv, 8,763 bioRxiv)

Most recent first Previous |  Page 196: Articles 1951-1960  | Next

The impact of non-pharmaceutical interventions on early-stage COVID-19 epidemic dynamics in rural communities in the United States
Alahakoon, P., Taylor, P. G., McCaw, J.
10.1101/2024.10.11.24315297 — Posted: 2024-10-11
Intranasal delivery of a broadly neutralizing single domain antibody targeting ACE2 protects against SARS-CoV-2 infection
Blachier, S., Fernandez, I., Conquet, L., Giraud, E., Staropoli, I., Michel, V., Szilagyi, F., Guez, S., Boucharlat, A., Chiaravalli, J., Tran-Rajau, J., Dufour, E., Petres, S., Planas, D., Montagutelli, X., Agou, F., Rey, F. A., Lafaye, P., Enninga, J., Ayme, G., Schwartz, O., Brelot, A.
10.1101/2024.10.11.617877 — Posted: 2024-10-11
Human tonsil organoids reveal innate pathways modulating humoral and cellular responses to ChAdOx1
Pudjohartono, M. F., Powell, K., Barnes, E., Klenerman, P., Provine, N. M.
10.1101/2024.10.11.617829 — Posted: 2024-10-11
Functional Activity and Binding Specificity of small Ankyron Repeat Proteins against SARS-CoV-2 variants
Park, Y.-J., Jankowski, W., Hurst, N. C., Fry, J. W., Schwabe, N. F., Tan, L. C. C., Sauna, Z. E.
10.1101/2024.10.11.617752 — Posted: 2024-10-11
Structural insights into the RNA binding inhibitors of the C-terminal domain of the SARS-CoV-2 nucleocapsid
Dhaka, P., Mahto, J. K., Singh, A., Kumar, P., Tomar, S.
10.1101/2024.10.11.617762 — Posted: 2024-10-11
A Benchmark of methods for SARS-CoV-2 whole genome sequencing and development of a more sensitive method
Bayega, A., Reiling, S., Dubuc, I., Gravel, A., Flamand, L., Ragoussis, I.
10.1101/2024.10.09.24313595 — Posted: 2024-10-10
Organizational resilience and its implications for healthcare workers in the COVID-19 pandemic: A literature review
Kaczmarski, K., Pasha, A., Inusah, A.-H., Li, X., Qiao, S.
10.1101/2024.10.10.24315244 — Posted: 2024-10-10
Distinct proteomic signatures in Ethiopians predict acute and long-term sequelae of COVID-19
Wolday, D., Gebrehiwot, A., Rameto, M. A., Abdella, S., Gebreegziabher, A., Amogne, W., Hailu, M., Tollera, G., Tasew, G., Tessema, M., Rinke de Wit, T. F., Miler, M., Mukhreji, M., Gilgrass, A., Bowdish, D. M. E., Kaushic, C., Verschoor, C. P.
10.1101/2024.10.09.24315196 — Posted: 2024-10-10
Multi-ancestry GWAS of Long COVID identifiesimmune-related loci and etiological links to chronic fatigue syndrome, fibromyalgia and depression
Chaudhary, N. S., Weldon, C. H., Nandakumar, P., 23andMe Research Team, , Holmes, M. V., Aslibekyan, S.
10.1101/2024.10.07.24315052 — Posted: 2024-10-09
Structural basis of TMPRSS11D specificity and autocleavage activation
Fraser, B. J., Wilson, R. P., Ilyassov, O., Lac, J., Dong, A., Li, Y.-Y., Seitova, A., Li, Y., Hejazi, Z., Kenney, T. M. G., Penn, L. Z., Edwards, A., Morin, G. B., Benard, F., Arrowsmith, C. H.
10.1101/2024.10.09.617371 — Posted: 2024-10-09

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).